logo
Universities to increase lower offers for disadvantaged students

Universities to increase lower offers for disadvantaged students

Telegraph23-04-2025

Universities are to increase the use of lower entry grade offers for disadvantaged students.
Vice-chancellors are being encouraged to allow more 'contextual admissions' to improve access for students who face barriers.
Universities UK (UUK), which represents 141 universities, has unveiled a plan for a 'more transparent and consistent approach' to contextual admissions which take into account a student's circumstances and background to recognise the barriers they may have faced.
Contextual admissions are already widely used across universities but there is currently no consistent approach to the practice. The offers are typically a grade or two lower than advertised course entry requirements and can also include guaranteed interviews or additional support.
As part of the new plan, named Access to Success, UUK, Ucas and the Sutton Trust will start a joint review of the criteria used for contextual admissions to encourage greater consistency across universities in England.
UUK said the current admissions system is 'hard to navigate and a barrier' which is potentially putting off young people who could benefit.
'Local cold spots'
The project aims to support universities in England with contextual admissions to ensure students are not prevented from reaching university because of their backgrounds.
The plan also calls on universities and the Government to raise aspirations by collaborating in 'local cold spots' where historically fewer people go into higher education.
UUK said: 'Our goal is to bring greater consistency to how universities approach contextual admissions and to encourage more universities to adopt them so that young people who meet the criteria can apply with greater confidence to the options available to them.'
It added that universities should work with schools and further education colleges to provide improved information and advice to help students in making the right choice.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Gambler bets some change on a slot machine in Florida — and wins big jackpot
Gambler bets some change on a slot machine in Florida — and wins big jackpot

Miami Herald

time4 minutes ago

  • Miami Herald

Gambler bets some change on a slot machine in Florida — and wins big jackpot

A gambler bet 88 cents on a slot machine at a Florida casino and won a big jackpot prize. The lucky player sat at a Fu Nan Fu Nu slot machine June 8 at Seminole Brighton Bay Hotel & Casino in Okeechobee, the casino said in a news release. The guest made a bet, hit spin and watched as the symbols flashed across the screen until a jackpot message appeared. The gambler then walked away $75,174.41 richer. Okeechobee is about a 70-mile drive northwest from West Palm Beach. Another gambler on the other side of the country also hit a slot machine jackpot with an 88-cent bet. The visitor sat at a Dancing Drums slot machine at Palms Casino Resort in Las Vegas and won a $28,733.01 jackpot, McClatchy News reported.

Judge Orders J&J Subsidiary to Pay $442 Million in Antitrust Lawsuit
Judge Orders J&J Subsidiary to Pay $442 Million in Antitrust Lawsuit

Yahoo

time5 minutes ago

  • Yahoo

Judge Orders J&J Subsidiary to Pay $442 Million in Antitrust Lawsuit

Johnson & Johnson (NYSE:JNJ) is one of the best Dow stocks to invest in. Recently, a federal judge ruled that a Johnson & Johnson subsidiary must pay $442 million in damages after a jury concluded last month that the company had broken antitrust laws by withholding support from hospitals that used reprocessed catheters. U.S. District Judge James Selna ordered the company to pay three times the $147 million in damages awarded by the jury, as permitted under antitrust regulations. This sum does not include legal fees or other related costs. Daniel Vukelich, CEO of the Association of Medical Device Reprocessors, described the decision as 'a seismic result.' In response, a Johnson & Johnson (NYSE:JNJ) spokesperson said the company intends to appeal the verdict but will comply with the court's decision and any required relief for now. The spokesperson added, 'We strongly disagree with the jury's verdict and believe it will not withstand appellate review.' Innovative Health sued Johnson & Johnson (NYSE:JNJ)'s Biosense Webster in 2019, claiming the company used its market power to block hospitals from using reprocessed heart-mapping catheters by tying support for its Carto 3 system to purchases of its own products. A jury found Johnson & Johnson (NYSE:JNJ) violated antitrust laws by withholding support for the reprocessed devices. AMDR's CEO said the ruling signals that anti-competitive tactics against reprocessing won't be tolerated. The case was heard in the U.S. District Court for the Central District of California. While we acknowledge the potential of JNJ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store